Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016)

Amarin Corp Plcuk (AMRN) posted quarterly Current Deferred Tax Assets of $900000.0 for Q4 2016, up 200.0% YoY from $300000.0 in Q1 2016, and up 200.0% sequentially from -$900000.0 in Q4 2015.

Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016) Analysis & Trends

Amarin Corp Plcuk has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $900000.0 for Q4 2016.

  • In Q4 2016, Current Deferred Tax Assets rose 200.0% year-over-year to $900000.0; the TTM figure through Dec 2016 stood at $900000.0 (up 200.0% YoY), while the FY2016 annual figure was $900000.0, up 200.0% from the prior year.
  • Current Deferred Tax Assets advanced to $900000.0 in Q4 2016, from -$900000.0 in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for AMRN reached as high as $937000.0 in Q4 2012 and fell as low as -$900000.0 in Q4 2015.
  • The 5-year median for Current Deferred Tax Assets is $900000.0 (2016), against an average of $645000.0.
  • Annual changes were most pronounced in 2015 — Current Deferred Tax Assets plunged 196.36% — and 2016, when it jumped 200.0%.
  • A 5-year view of Current Deferred Tax Assets shows it stood at $937000.0 in 2012, then tumbled by 49.73% to $471000.0 in 2013, then surged by 98.3% to $934000.0 in 2014, then sank by 196.36% to -$900000.0 in 2015, then jumped by 200.0% to $900000.0 in 2016.
  • According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $900000.0, -$900000.0, and $934000.0 for Q4 2016, Q4 2015, and Q3 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2016 900,000.00
Dec 31, 2016 900,000.00
Dec 31, 2015 -900,000.00
Dec 31, 2015 -900,000.00
Sep 30, 2015 934,000.00
Sep 30, 2015 934,000.00
Jun 30, 2015 934,000.00
Jun 30, 2015 934,000.00
Mar 31, 2015 934,000.00
Mar 31, 2015 934,000.00
Dec 31, 2014 934,000.00
Dec 31, 2014 934,000.00
Sep 30, 2014 471,000.00
Sep 30, 2014 471,000.00
Jun 30, 2014 471,000.00
Jun 30, 2014 471,000.00
Mar 31, 2014 471,000.00
Mar 31, 2014 471,000.00
Dec 31, 2013 471,000.00
Dec 31, 2013 471,000.00